Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance

Background. Pancreatic tumors are rare and could arise from either the exocrine (ductal and acinar cells) or the endocrine (neuroendocrine cells) components of the pancreas. In some instances, the occurrence of pancreatic tumors comprising both acinar cells and neuroendocrine cells, with neuroendocr...

Full description

Bibliographic Details
Main Authors: Onyekachi Henry Ogbonna, Marie Carmel Garcon, Kostas N. Syrigos, Muhammad Wasif Saif
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2013/705092
id doaj-82169139a84e4b319ab98b2149a35410
record_format Article
spelling doaj-82169139a84e4b319ab98b2149a354102020-11-24T21:37:04ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352013-01-01201310.1155/2013/705092705092Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine PredominanceOnyekachi Henry Ogbonna0Marie Carmel Garcon1Kostas N. Syrigos2Muhammad Wasif Saif3Section of GI Cancers and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111, USAColumbia University Medical Center, New York, NY 10032, USAOncology Unit, Third Department of Medicine, Athens University, School of Medicine, Sotiria General Hospital, 115 27 Athens, GreeceSection of GI Cancers and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111, USABackground. Pancreatic tumors are rare and could arise from either the exocrine (ductal and acinar cells) or the endocrine (neuroendocrine cells) components of the pancreas. In some instances, the occurrence of pancreatic tumors comprising both acinar cells and neuroendocrine cells, with neuroendocrine cells making up more than 30% of the tumor, has been identified. This unique entity has been referred to as mixed acinar-neuroendocrine carcinoma (MANEC). Only about 20 such cases have been reported in the literature. Case Report. We report an interesting case of MANEC with neuroendocrine cell predominance in a woman presenting with epigastric pain secondary to a pancreatic mass with acinar and endocrine differentiation. She underwent surgical resection of the tumor and was offered adjuvant treatment chemotherapy with carboplatin, etoposide, and radiotherapy for positive tumor resection margins. Conclusions. Given the paucity of the cases of MANEC, continuous reporting of these cases when identified should be encouraged to aid oncologists in understanding the disease and help establish standardized management.http://dx.doi.org/10.1155/2013/705092
collection DOAJ
language English
format Article
sources DOAJ
author Onyekachi Henry Ogbonna
Marie Carmel Garcon
Kostas N. Syrigos
Muhammad Wasif Saif
spellingShingle Onyekachi Henry Ogbonna
Marie Carmel Garcon
Kostas N. Syrigos
Muhammad Wasif Saif
Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
Case Reports in Medicine
author_facet Onyekachi Henry Ogbonna
Marie Carmel Garcon
Kostas N. Syrigos
Muhammad Wasif Saif
author_sort Onyekachi Henry Ogbonna
title Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_short Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_full Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_fullStr Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_full_unstemmed Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
title_sort mixed acinar-neuroendocrine carcinoma of the pancreas with neuroendocrine predominance
publisher Hindawi Limited
series Case Reports in Medicine
issn 1687-9627
1687-9635
publishDate 2013-01-01
description Background. Pancreatic tumors are rare and could arise from either the exocrine (ductal and acinar cells) or the endocrine (neuroendocrine cells) components of the pancreas. In some instances, the occurrence of pancreatic tumors comprising both acinar cells and neuroendocrine cells, with neuroendocrine cells making up more than 30% of the tumor, has been identified. This unique entity has been referred to as mixed acinar-neuroendocrine carcinoma (MANEC). Only about 20 such cases have been reported in the literature. Case Report. We report an interesting case of MANEC with neuroendocrine cell predominance in a woman presenting with epigastric pain secondary to a pancreatic mass with acinar and endocrine differentiation. She underwent surgical resection of the tumor and was offered adjuvant treatment chemotherapy with carboplatin, etoposide, and radiotherapy for positive tumor resection margins. Conclusions. Given the paucity of the cases of MANEC, continuous reporting of these cases when identified should be encouraged to aid oncologists in understanding the disease and help establish standardized management.
url http://dx.doi.org/10.1155/2013/705092
work_keys_str_mv AT onyekachihenryogbonna mixedacinarneuroendocrinecarcinomaofthepancreaswithneuroendocrinepredominance
AT mariecarmelgarcon mixedacinarneuroendocrinecarcinomaofthepancreaswithneuroendocrinepredominance
AT kostasnsyrigos mixedacinarneuroendocrinecarcinomaofthepancreaswithneuroendocrinepredominance
AT muhammadwasifsaif mixedacinarneuroendocrinecarcinomaofthepancreaswithneuroendocrinepredominance
_version_ 1725938382463303680